Crystal Tomato
Crystal Tomato Whitening Supplements: Clinically Proven Skin Brightening for Radiant, Luminous Skin
Crystal Tomato Whitening Supplements: Clinically Proven Skin Brightening for Radiant, Luminous Skin
Couldn't load pickup availability
Product Overview
Crystal Tomato® is a Singapore-developed oral whitening supplement built around colourless carotenoids (phytoene and phytofluene), the immediate biosynthetic precursors of the better-known coloured carotenoids lycopene and beta-carotene. The active raw material is sourced from a proprietary non-GMO tomato cultivar reported by the manufacturer to contain approximately 500-fold higher bio-accessible colourless carotenoid content than standard tomatoes. Unlike the coloured carotenoids, phytoene and phytofluene do not absorb in the visible spectrum and have absorption maxima in the UV-B/UV-A range, providing photo-stabilising and antioxidant properties when distributed to the skin via the systemic circulation.
Mechanistically, oral phytoene/phytofluene supplementation has been associated with reduced UV-induced erythema, attenuated melanogenesis (inhibition of tyrosinase activity in vitro) and a reduction in oxidative-stress-driven post-inflammatory hyperpigmentation. Clinical evaluation at the National Skin Centre Singapore demonstrated statistically significant reductions in mMASI scores and improvement in skin luminosity over 54 days. Crystal Tomato® is intended for use under the guidance of a dermatologist or aesthetic physician as part of an integrated regimen that includes broad-spectrum sunscreen, topical depigmenting agents and avoidance of UV exposure.
Specifications
| Manufacturer / Brand | Crystal Tomato® — distributed and developed in Singapore |
|---|---|
| Product | Crystal Tomato® Whitening Supplement (oral pigmentation management) |
| Active actives | Standardised colourless carotenoids: phytoene and phytofluene from proprietary non-GMO tomato cultivar |
| Dosage form | Oral tablet, once-daily dosing |
| Pack size | 30 tablets (one-month supply) |
| Suggested course | Dermatologist-supervised; clinical evidence is based on 54-day continuous use |
| Dietary attributes | Non-GMO source material; manufacturer states absence of artificial colourants and added hydroquinone |
| Manufacturing standards | Manufactured under cGMP; raw material supplied under exclusive arrangement (Lucas Meyer Cosmetics enhanced colourless carotenoid platform, 2024) |
| Clinical evidence | Double-blind, randomised, placebo-controlled clinical trial conducted at the National Skin Centre, Singapore; published in the U.S. Journal of Pigmentary Disorders. |
| Key endpoints | −46% mMASI in active arm vs −35% placebo at day 54; up to 8.9× greater reduction in erythema score; no significant adverse events reported. |
| Regulatory positioning | Health Sciences Authority (HSA) Singapore: classified as a health supplement under the Health Products Act, not a registered therapeutic product or medical device. Not intended to diagnose, treat, cure, or prevent any disease. |
Key Applications
- Adjunctive oral therapy in dermatologist-managed melasma and post-inflammatory hyperpigmentation, alongside topical agents such as hydroquinone, azelaic acid and tranexamic acid.
- Maintenance phase support after laser, intense pulsed light (IPL) or chemical peel pigmentation procedures, where reactivation of melanogenesis is a known risk.
- Tonal evening and reduction of solar lentigines as part of a structured photoprotection programme in adults with Fitzpatrick III–V phototypes.
- Patients seeking a non-prescription oral adjunct to broad-spectrum SPF 50+ sunscreen and physical photoprotection.
- Long-haul travellers and outdoor professionals with cumulative UV exposure.
Frequently Asked Questions
What is the clinical evidence supporting Crystal Tomato® Whitening Supplement?
The product was evaluated in a double-blind, placebo-controlled, randomised clinical trial conducted at the National Skin Centre, Singapore. The active arm achieved a 46% reduction in modified MASI (mMASI) versus 35% on placebo, with up to 8.9-fold greater improvement in erythema (redness) at 54 days. The study was published in the U.S. Journal of Pigmentary Disorders. Patients should still apply broad-spectrum sunscreen daily; oral supplementation is adjunctive, not substitutive.
Are colourless carotenoids the same as "white tomato" extract?
No. The active phytoene and phytofluene fraction is derived from a proprietary non-GMO red tomato cultivar selectively bred for high colourless-carotenoid yield. The product does not contain hydroquinone, glutathione injectables or skin-bleaching pharmaceuticals.
Is Crystal Tomato® registered with HSA in Singapore?
The product is supplied as a health supplement under Singapore's Health Products Act regime administered by the Health Sciences Authority (HSA). It is not a registered therapeutic product or medical device. Patients with diagnosed melasma, drug-induced hyperpigmentation or post-inflammatory hyperpigmentation should be evaluated by a dermatologist; supplementation is intended as adjunct to medical management.
Is it safe in pregnancy or with prescription medication?
Use during pregnancy or lactation is not recommended without prior medical advice given the absence of dedicated safety studies in those populations. Patients on retinoid therapy, photosensitising medications (e.g., tetracyclines, amiodarone) or with known carotenoid hypersensitivity should consult their treating physician before initiation.
How long before results are visible?
Published clinical data show measurable mMASI reduction at 54 days. In aesthetic-medicine practice a minimum 8–12 week course is typically recommended, supported by daily SPF 50+ sunscreen and topical depigmenting therapy as prescribed.
Share
